Pyrazolopyridine kinase inhibitors

Details for Australian Patent Application No. 2011209644 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Jimenez, Juan-Miguel; Golec, Julian M.C.; Settimo, Luca; Fraysse, Damien; Brenchley, Guy; Boyall, Dean; Twin, Heather; Young, Stephen; Miller, Andrew W.; Davis, Christopher John; Collier, Phillip

Agent Baldwins

Pub. Number AU-A-2011209644

PCT Pub. Number WO2011/094283

Priority 61/298,653 27.01.10 US

Filing date 26 January 2011

Wipo publication date 4 August 2011

International Classifications

C07D 471/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/496 - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61P 25/00 Drugs for disorders of the nervous system

A61P 29/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 Antineoplastic agents

A61P 37/00 Drugs for immunological or allergic disorders

Event Publications

9 August 2012 PCT application entered the National Phase

  PCT publication WO2011/094283 Priority application(s): WO2011/094283

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011209649-Pyrazolopyrazine kinase inhibitors

2011209626-Influenza nucleic acid molecules and vaccines made therefrom